EU regulator endorses Amicus combination therapy for muscle disorder

Amicus Therapeutics

16/12/2022 13:24

Dec 16 (Reuters) - The European Union's health regulator
said on Friday it had recommended granting marketing
authorization for Amicus Therapeutics Inc's  FOLD.O 
experimental combination therapy to treat a muscle disorder
called Pompe disease.
 (Reporting by Khushi Mandowara; Editing by Krishna Chandra
Eluri)
 ((Khushi.Mandowara@thomsonreuters.com;))